This webinar series will update you on the latest USP developments in Particulate Matter.

This webinar will focus on gray zone particles. Discussions will define the current concerns related to gray zone particles and the current USP chapters that touch on the topic. The webinar will focus on several case studies, a discussion of the Knapp Study Concept (thresholding), supplemental testing, and action limits of targets.

Participants will be offered the opportunity to ask questions during the last segment of the session.

Subject area:
Drug Products & APIs

Objectives (If applicable):
n/a

Target Audience (If applicable):
Laboratory scientists
Lab managers
QA/QC staff in the pharmaceutical and allied industries
Regulatory professionals
Scientists with interest in Particulate Matter